BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25796184)

  • 1. PEA-15 facilitates EGFR dephosphorylation via ERK sequestration at increased ER-PM contacts in TNBC cells.
    Shin M; Lee KE; Yang EG; Jeon H; Song HK
    FEBS Lett; 2015 Apr; 589(9):1033-9. PubMed ID: 25796184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
    Glading A; Koziol JA; Krueger J; Ginsberg MH
    Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
    Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
    Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
    Yang Z; Barnes CJ; Kumar R
    Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloprotease-dependent activation of EGFR modulates CD44
    Wise R; Zolkiewska A
    Breast Cancer Res Treat; 2017 Nov; 166(2):421-433. PubMed ID: 28791489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine.
    Ghosh S; Adhikary A; Chakraborty S; Bhattacharjee P; Mazumder M; Putatunda S; Gorain M; Chakraborty A; Kundu GC; Das T; Sen PC
    J Biol Chem; 2015 Feb; 290(7):3936-49. PubMed ID: 25527500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of PEA-15 reverses G1 arrest, and nuclear and chromatin changes of senescence phenotype via pErk1/2 translocation to nuclei.
    Lee YY; Kim HS; Lim IK
    Cell Signal; 2015 Jun; 27(6):1102-9. PubMed ID: 25725291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD.
    Renganathan H; Vaidyanathan H; Knapinska A; Ramos JW
    Biochem J; 2005 Sep; 390(Pt 3):729-35. PubMed ID: 15916534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.
    Haling JR; Wang F; Ginsberg MH
    Mol Biol Cell; 2010 Feb; 21(4):664-73. PubMed ID: 20032303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation.
    Krueger J; Chou FL; Glading A; Schaefer E; Ginsberg MH
    Mol Biol Cell; 2005 Aug; 16(8):3552-61. PubMed ID: 15917297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
    Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
    Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments.
    García-Fuster MJ; Díez-Alarcia R; Ferrer-Alcón M; La Harpe R; Meana JJ; García-Sevilla JA
    Neuroscience; 2014 Sep; 277():541-51. PubMed ID: 25075716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PEA-15/PED protein regulates cellular survival and invasiveness in colorectal carcinomas.
    Funke V; Lehmann-Koch J; Bickeböller M; Benner A; Tagscherer KE; Grund K; Pfeifer M; Herpel E; Schirmacher P; Chang-Claude J; Brenner H; Hoffmeister M; Roth W
    Cancer Lett; 2013 Jul; 335(2):431-40. PubMed ID: 23481023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency.
    Shapira I; Lee A; Vora R; Budman DR
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):284-92. PubMed ID: 23755891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.